Association between immune-related adverse events and recurrence dynamics under adjuvant anti–PD-1 therapy in resected melanoma

IntroductionAdjuvant anti–PD-1 therapy has significantly improved recurrence-free survival (RFS) in patients with resected high-risk melanoma, yet a substantial proportion still relapse. Identifying predictors of recurrence remains a clinical priority.MethodsWe retrospectively analyzed 84 patients w...

Descrición completa

Detalles Bibliográficos

Principais autores:	Gökhan Şahin, Caner Acar, Haydar Çağatay Yüksel, Salih Tünbekici, Pınar Açar, Banu Yaman, Burçak Karaca
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-11-01
Series:	Frontiers in Oncology
Assuntos:	melanoma immune-related adverse events anti–PD-1 therapy recurrence-free survival adjuvant immunotherapy cutaneous irAEs
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1671315/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!